Semaglutide
Brand name: Ozempic
Rank #2 of 500 drugs by total cost
$4.30B
Total Cost
3,193,643
Total Claims
$4.30B
Total Cost
71,812
Prescribers
$1,347
Cost per Claim
517,958
Beneficiaries
4,508,795
30-Day Fills
$60K
Avg Cost/Provider
44
Avg Claims/Provider
About Semaglutide
Semaglutide (sold as Ozempic) was prescribed 3,193,643 times by 71,812 Medicare Part D providers in 2023, costing the program $4.30B. At $1,347 per claim, this is a high-cost medication.
💰 This drug alone accounts for 1.6% of all Medicare Part D drug spending.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 1 | Apixaban (Eliquis) | $7.75B | 8,995,930 |
| 2 | Semaglutide (Ozempic) | $4.30B | 3,193,643 |
| 3 | Empagliflozin (Jardiance) | $3.58B | 3,334,784 |
| 4 | Dulaglutide (Trulicity) | $2.99B | 2,175,100 |
| 5 | Rivaroxaban (Xarelto) | $2.45B | 2,628,123 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology